Samenvatting: Kras/Volendam - JD Techniek/Hurry Up

(3:24)

Resistance in BRAF and KRAS Mutant Cancers - by Ryan Corcoran, MD, PhD

(47:45)

We're Finally Beginning to Crack the KRAS Nut in Colorectal Cancer

(4:46)

Sotorasib plus Panitumumab in KRAS-Mutated Colorectal Cancer | NEJM

(2:17)

KRAS Mutations in Solid Tumors

(6:52)

The Many Faces of KRAS. (KRAS episode 3)

(1:13)

Strategies for Overcoming KRAS Mutations

(21:36)

Cancer cell biology: mutated KRAS \u0026 reciprocal signalling

(2:25)

Overview of KRAS-Mutant Lung Adenocarcinoma

(2:31)

KRAS, NRAS, BRAF, HER2 and MSI Status in a Large Consecutive Series of Colorectal Car... | RTCL.TV

(54)

KRAS mutation

(13:59)

It's KRAS Biomarker Lung Cancer. What Do I Do Now?

(2:35)

Samenvatting Kras/Volendam Sezoens Achilles Bocholt

(3:30)

KRAS mutation: from undruggable to druggable in cancer | RTCL.TV

(1:14)

KRAS-Mutant NSCLC

(7:)

Daniel Ahn, D.O., M.S. discusses Targeting KRAS in Colorectal Cancer

(34:10)

The potential of KRAS inhibitors for non-small-cell lung cancer

(10:34)

Real-world outcomes by co-mutation status in KRAS G12C-mutant NSCLC

(5:14)

Innovative Approaches to Investigating KRAS Therapeutics with Biochemical and Cell Based Assays 2

(31:44)

Targeting KRAS G12C: Amgen's Breakthrough Treatment - Insights from I-Fen Chang and Terri Conneran

(1:18:54)